Acceleration of bone development and regeneration through the Wnt/β-catenin signaling pathway in mice heterozygously deficient for GSK-3β

被引:34
作者
Arioka, Masaki [1 ,2 ]
Takahashi-Yanaga, Fumi [1 ,3 ]
Sasaki, Masanori [2 ]
Yoshihara, Tatsuya [1 ]
Morimoto, Sachio [1 ]
Takashima, Akihiko [4 ]
Mori, Yoshihide [2 ]
Sasaguri, Toshiyuki [1 ]
机构
[1] Kyushu Univ, Fac Med Sci, Dept Clin Pharmacol, Fukuoka 8128582, Japan
[2] Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Surg, Fukuoka 8128582, Japan
[3] Kyushu Univ, Fac Med Sci, Global Med Sci Educ Unit, Fukuoka 8128582, Japan
[4] Natl Ctr Geriatr & Gerontol, Dept Aging Neurobiol, Oobu, Japan
关键词
Bone regeneration; GSK-3; beta; Wnt/beta-catenin signaling pathway; OSTEOBLAST DIFFERENTIATION; IN-VIVO; MASS; EXPRESSION; LRP5; OSTEOGENESIS; ACTIVATOR; DISEASE; CBFA1; CELLS;
D O I
10.1016/j.bbrc.2013.09.126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen synthase kinase (GSK)-3 beta plays an important role in osteoblastogenesis by regulating the Wnt/beta-catenin signaling pathway. Therefore, we investigated whether GSK-3 beta deficiency affects bone development and regeneration using mice heterozygously deficient for GSK-3 beta (GSK-3 beta(+/-)). The amounts of beta-catenin, c-Myc, cyclin D1, and runt-related transcription factor-2 (Runx2) in the bone marrow cells of GSK-3 beta(+/-) mice were significantly increased compared with those of wild-type mice, indicating that Wnt/beta-catenin signals were enhanced in GSK-3 beta(+/-) mice. Microcomputed tomography of the distal femoral metaphyses demonstrated that the volumes of both the cortical and trabecular bones were increased in GSK-3 beta(+/-) mice compared with those in wild-type mice. Subsequently, to investigate the effect of GSK-3 beta deficiency on bone regeneration, we established a partial bone defect in the femur and observed new bone at 14 days after surgery. The volume and mineral density of the new bone were significantly higher in GSK-3 beta(+/-) mice than those in wild-type mice. These results suggest that bone formation and regeneration in vivo are accelerated by inhibition of GSK-3 beta, probably through activation of the Wnt/beta-catenin signaling pathway. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:677 / 682
页数:6
相关论文
共 27 条
[21]   Lithium treatment at 52 [J].
Schou, M .
JOURNAL OF AFFECTIVE DISORDERS, 2001, 67 (1-3) :21-32
[22]   Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells [J].
Takahashi-Yanaga, F ;
Taba, Y ;
Miwa, Y ;
Kubohara, Y ;
Watanabe, Y ;
Hirata, M ;
Morimoto, S ;
Sasaguri, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9663-9670
[23]   Activator or inhibitor? GSK-3 as a new drug target [J].
Takahashi-Yanaga, Fumi .
BIOCHEMICAL PHARMACOLOGY, 2013, 86 (02) :191-199
[24]   Wnt signaling in osteoblasts and bone diseases [J].
Westendorf, JJ ;
Kahler, RA ;
Schroeder, TM .
GENE, 2004, 341 :19-39
[25]  
Whyte MP, 2004, NEW ENGL J MED, V350, P2096
[26]   Lithium's effect on bone mineral density [J].
Zamani, Ali ;
Omrani, Gholamhossein R. ;
Nasab, Masoud Mousavi .
BONE, 2009, 44 (02) :331-334
[27]   GSK-3α is a central regulator of age-related pathologies in mice [J].
Zhou, Jibin ;
Freeman, Theresa A. ;
Ahmad, Firdos ;
Shang, Xiying ;
Mangano, Emily ;
Gao, Erhe ;
Farber, John ;
Wang, Yajing ;
Ma, Xin-Liang ;
Woodgett, James ;
Vagnozzi, Ronald J. ;
Lal, Hind ;
Force, Thomas .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (04) :1821-1832